Vanguard Small-Cap 600 ETF to Gain 0.3% from Hims & Hers’ 49% Rally
Hims & Hers shares jumped 48.67% premarket after resolving its patent dispute with Novo Nordisk and launching a weight-loss drug partnership, potentially boosting Vanguard S&P Small-Cap 600 Index Fund ETF’s NAV. As Hims & Hers accounts for 0.64% of VIOO’s portfolio, the rally could add approximately 0.31% to its NAV.
1. HIMS Share Surge and Legal Resolution
Hims & Hers Health shares rose 48.67% in premarket trading after settling its patent dispute with Novo Nordisk and securing distribution rights for Novo Nordisk’s weight-loss drug on its telehealth platform.
2. Impact on VIOO ETF
With Hims & Hers representing 0.64% of the Vanguard S&P Small-Cap 600 Index Fund ETF, the share price jump translates to an estimated 0.31% NAV increase for VIOO, demonstrating how single-stock catalysts can meaningfully influence small-cap ETF returns.